Hospital Pediatrics· 2026Q1
Intrapleural TPA vs Normal Saline in Pediatric Empyema: A Comparative Study
- 0citations
- Q1SCImago
- 2026year
Short summary
Intrapleural tissue plasminogen activator (TPA) did not significantly reduce hospital length of stay (LOS) compared to normal saline in children with empyema, with a mean LOS of 20.28 days for TPA versus 19.17 days for saline.
AI-generated from the title and abstract; the full text is not read.
Key points
- Intrapleural TPA did not reduce hospital length of stay (LOS) in pediatric empyema patients compared to normal saline (20.28 vs 19.17 days).
- Secondary outcomes including ICU stay, fever duration, and chest-tube duration also showed no significant differences.
- The study found no detectable benefit of TPA over saline, with confidence intervals compatible with no clinically important effect.
- Residual confounding and selection bias cannot be excluded as potential limitations.
AI-generated from the title and abstract; the full text is not read.
Abstract
OBJECTIVE To determine whether intrapleural tissue plasminogen activator (TPA) reduces hospital length of stay (LOS) vs intrapleural normal saline in children with complicated parapneumonic effusion or empyema. METHODS A retrospective cohort study at a tertiary pediatric referral hospital in Iran, comparing children aged 1 month to 18 years treated during TPA unavailability (2012–2015; intrapleural saline, 40 mL, 1-hour dwell, daily ×3 days) with those treated after TPA became available (2015–2018; TPA 4 mg in 40 mL saline, same protocol). The primary outcome was hospital LOS, and the secondary outcomes were intensive care unit (ICU) stay, fever duration, chest-tube duration, and ICU admission. Multivariable linear regression was adjusted for baseline imbalances between cohorts. RESULTS Of 85 patients, 61 received TPA and 24 saline. The cohorts were comparable at baseline, except for higher pleural fluid adenosine deaminase and shorter time to first instillation in the saline group (medium and very large effects). The mean hospital LOS was 20.28 ± 5.53 days (TPA) vs 19.17 ± 3.60 days (saline). The unadjusted difference was 1.11 days (95% CI, −1.14 to 3.36; P = .366). The adjusted mean difference was 0.36 days (95% CI, −2.91 to 3.63; P = .826). Secondary outcomes showed similarly small differences, with CI ranges compatible with no clinically important effect. CONCLUSIONS Intrapleural TPA showed no detectable benefit over saline in this retrospective comparison. The wide CI ranges indicate insufficient evidence to reject the null hypothesis and not equivalence. Our findings raise, but do not confirm, the hypothesis that mechanical lavage contributes to clinical improvement. Residual confounding and selection bias cannot be excluded. Adequately powered, prospective randomized trials are needed to establish the incremental value of fibrinolysis in children.
The authors' abstract, as published at the source. Hospital Pediatrics, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pulmonary and Respiratory Medicine
Pulmonary and Respiratory MedicineMedicine